ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 632,08
1,24%
Dow Jones
39 308,00
-0,06%
DAX
18 374,53
1,22%
Brent Oil
86,91
0,54%
Bitcoin
60 281,33
-2,81%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Trinity Biotech PLC (TRIB)

  7. Trinity Biotech PLC (TRIB) Actualités

TRIB

Trinity Biotech (TRIB)

Trinity Biotech PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TRIB
DateHeureSourceTitreSymboleSociété
24/06/202413h00GlobeNewswire Inc.Trinity Biotech to Begin European Pre-Pivotal Trial to Optimize its CGM SensorNASDAQ:TRIBTrinity Biotech PLC
10/06/202415h10GlobeNewswire Inc.Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes AssociationNASDAQ:TRIBTrinity Biotech PLC
03/06/202410h00GlobeNewswire Inc.Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated TechnologyNASDAQ:TRIBTrinity Biotech PLC
28/05/202413h55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
23/05/202414h00GlobeNewswire Inc.Trinity Biotech Announces Q1 2024 Financial Results and Reiterates GuidanceNASDAQ:TRIBTrinity Biotech PLC
16/05/202415h18GlobeNewswire Inc.Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAINASDAQ:TRIBTrinity Biotech PLC
13/05/202417h42GlobeNewswire Inc.Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV SalesNASDAQ:TRIBTrinity Biotech PLC
08/05/202416h36GlobeNewswire Inc.Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and DevelopmentNASDAQ:TRIBTrinity Biotech PLC
08/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRIBTrinity Biotech PLC
07/05/202422h25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
04/04/202413h30GlobeNewswire Inc.Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business UpdatesNASDAQ:TRIBTrinity Biotech PLC
28/03/202423h39GlobeNewswire Inc.Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
08/03/202416h03GlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price RuleNASDAQ:TRIBTrinity Biotech PLC
15/02/202418h34GlobeNewswire Inc.Trinity Biotech Plc Finalizes Effective Date of ADS Ratio ChangeNASDAQ:TRIBTrinity Biotech PLC
13/02/202415h00GlobeNewswire Inc.Trinity Biotech Plc Announces Plan to Implement ADS Ratio ChangeNASDAQ:TRIBTrinity Biotech PLC
10/02/202401h51Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TRIBTrinity Biotech PLC
08/02/202414h30GlobeNewswire Inc.Trinity Biotech to Present at Emerging Growth ConferenceNASDAQ:TRIBTrinity Biotech PLC
07/02/202414h30GlobeNewswire Inc.Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA CodeNASDAQ:TRIBTrinity Biotech PLC
31/01/202413h05GlobeNewswire Inc.Trinity Biotech Announces Q3 2023 Financial Results & Business UpdateNASDAQ:TRIBTrinity Biotech PLC
31/01/202413h02GlobeNewswire Inc.Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and IndiaNASDAQ:TRIBTrinity Biotech PLC
31/01/202413h00GlobeNewswire Inc.Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.NASDAQ:TRIBTrinity Biotech PLC
30/01/202423h23GlobeNewswire Inc.Trinity Biotech plc to Host Investor CallNASDAQ:TRIBTrinity Biotech PLC
02/01/202422h17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
27/12/202314h57GlobeNewswire Inc.Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to KenyaNASDAQ:TRIBTrinity Biotech PLC
18/12/202322h30GlobeNewswire Inc.Trinity Biotech Announces Management ChangesNASDAQ:TRIBTrinity Biotech PLC
28/11/202322h05GlobeNewswire Inc.Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held SharesNASDAQ:TRIBTrinity Biotech PLC
10/10/202314h15GlobeNewswire Inc.Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of HealthNASDAQ:TRIBTrinity Biotech PLC
03/10/202315h15GlobeNewswire Inc.Trinity Biotech Announces Q2 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
03/10/202313h58IH Market NewsTuesday’s Wall Street Highlights: GM, Airbnb, Tesla, Apple, Oddity Tech, and moreNASDAQ:TRIBTrinity Biotech PLC
27/09/202318h50GlobeNewswire Inc.Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
 Showing the most relevant articles for your search:NASDAQ:TRIB

Dernières Valeurs Consultées

LSE
CTSU
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés